ID: ALA436894

Max Phase: Preclinical

Molecular Formula: C64H86N14O15S

Molecular Weight: 1323.54

Molecule Type: Protein

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O

Standard InChI:  InChI=1S/C64H86N14O15S/c1-7-35(6)54(63(91)75-49(64(92)93)26-38-29-68-43-16-12-11-15-41(38)43)78-62(90)53(34(4)5)77-60(88)48(28-52(81)82)74-56(84)44(21-22-51(66)80)70-59(87)47(27-39-30-67-32-69-39)73-61(89)50(31-94)76-58(86)46(24-36-13-9-8-10-14-36)72-57(85)45(25-37-17-19-40(79)20-18-37)71-55(83)42(65)23-33(2)3/h8-20,29-30,32-35,42,44-50,53-54,68,79,94H,7,21-28,31,65H2,1-6H3,(H2,66,80)(H,67,69)(H,70,87)(H,71,83)(H,72,85)(H,73,89)(H,74,84)(H,75,91)(H,76,86)(H,77,88)(H,78,90)(H,81,82)(H,92,93)/t35-,42-,44-,45-,46-,47-,48-,49-,50-,53-,54-/m0/s1

Standard InChI Key:  SFSIFZZQDRPMDO-CSJJGNFLSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Protein

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 1323.54

Molecular Weight (Monoisotopic): 1322.6118

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Suzawa T, Shibata K, Tanaka T, Matsuda Y, Yamasaki M.  (1997)  RES-701-1/endothelin-1 hybrid peptide having a potent binding activity for type B receptor,  7  (13): [10.1016/S0960-894X(97)00296-5]

Source

Source(1):

• Scientific Literature